CC
RARE icon

Clearline Capital’s Ultragenyx Pharmaceutical RARE Stock Holding History

Clearline Capital’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-32,961
Closed -$1.35M – 162
2024
Q2 		$1.35M Buy
+32,961
New +$1.35M 0.04% 108